AHA Scientific Sessions 2025 Abstract

Inclisiran Nonresponse with PCSK9 Variant and Successful LDL-C Lowering with Evinacumab in a Patient with Homozygous Familial Hypercholesterolemia

The paper

Methodist Dallas Medical Center; Dallas VA Medical Center

AHA Scientific Sessions 2025 Abstract, 3 Nov 2025

Presented at AHA Scientific Sessions 2025, abstract 4338231

doi.org/10.1161/circ.152.suppl_3.4338231